Manufacturing facility

Manufacturing

Production readiness, documented end to end

The company profile documents COVID-19 vaccine production readiness across upstream and downstream processes, formulation, fill-finish, and supporting systems. The figures below are reproduced from that source document and presented as documented readiness — not as current commercial output.

Figures are sourced from the official company profile. They describe documented production readiness and must not be interpreted as current operating capacity, present-day certification, regulatory approval, or commercial output.

Process flow

From upstream to finished vials

  1. A

    Upstream Process

    Cell propagation and inoculation using 1 set bioreactor system with capacity of 20 L, up scaling to 200 L.

    • Cell Propagation and Inoculation
    • 1 set bioreactor system, 20 L capacity, up scaling to 200 L
  2. B

    Harvesting and Purification

    Harvesting and purification of bulk antigen prior to storage.

    • 1 harvesting tank (200 L)
    • 2 mobile tanks (200 L)
    • 1 separator machine
    • 1 ultrafiltration machine
  3. B

    Ready to Fill Bulk Antigen

    Bulk antigen stored and controlled in a sterile area prior to downstream processing.

    • 5 coldrooms (sterile area) with total area of 250 m³
    • Total effective storage area (40%) equal to 100,000 litres
    • Documented equivalent: 200,000,000 doses
  4. 2

    Downstream Process — Formulation

    Formulation stage using dedicated mobile tanks.

    • 6 mobile tanks with volume of 200 litres each
    • Total effective process capacity equal to 1,200 litres
    • Documented equivalent: 2,400,000 doses
  5. Filling

    Filling, Capping, Inspection, Labelling, Packaging, Storage

    Fill-finish operations with documented capacities.

    • Filling: 1 set filling machine, capacity 15,000 vial/hour — volume 5 ml/vial
    • Operation time 16 hours/day (bottle neck)
    • 15,000 vial/hour × 16 hours = 240,000 vials/day (equal to 1,200 litres formula)
    • Documented equivalent: 2,400,000 doses/day
    • Capping: 1 set capping machine
    • Vial inspection: 1 set
    • Labelling: 1 set
    • Packaging: 1 set
    • Storage: included
  6. Vial Washing

    Vial Washing and Dry Heat Sterilization

    Vial washing and sterilization supporting the fill-finish line.

    • 1 set vial washing and dry heat sterilization machine
    • Capacity: 20,000 vial/hour

Supporting systems

Utility and process support equipment

  • Inactivation: 9 inactivation tanks with capacity of 2,000 litres each
  • White Oil Preparation: 1 heating oil tank (3,500 L), 2 cooling oil tanks (3,500 L)
  • Water Phase Preparation: 3 premix tanks (1,000 L)
  • Emulsification: 3 emulsification tanks (1,000 L)
  • Finish tanks: 1 finish tank (3,500 L), 1 finish tank (4,500 L)
  • Vial Washing Machine: 1 set, 20,000 vials/hour, ultrasonic vial washing
  • Filling & Rubbering: 1 set filling machine, 20,000 vials/hour
  • Capping: 1 set capping machine, 20,000 vials/hour
  • Labelling: 1 set labelling machine, 20,000 vials/hour

Workshop A

720,000,000 doses/year

The company profile documents Workshop A at 720,000,000 doses/year, alongside a separate documented figure of 2,880,000,000 doses/year. These figures are reproduced as documented readiness and are not presented as current commercial output.

Discuss production with Biotis

For manufacturing, supply, or partnership enquiries, please contact our team.

Contact us